OptiBiotix Health Plc

Research OptiBiotix Health Plc (OPTI) on Bullrun: market cap GBX 593.98M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is GBX 593.98M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025GBP 1.17M-GBP 3.89M-GBP 1.77M52.7%-0.04GBP 1.04Mn/aGBP 6.28M
FY2024GBP 870.00K-GBP 1.81M-GBP 1.77M38.0%-0.02GBP 739.00Kn/aGBP 8.40M
FY2023GBP 644.00K-GBP 2.04M-GBP 1.53M49.7%-0.02GBP 635.00Kn/aGBP 8.87M
FY2022GBP 457.00KGBP 2.59M-GBP 1.28M53.4%0.03GBP 1.05MGBP 0GBP 10.91M
FY2021GBP 2.21MGBP 6.26M-GBP 1.76M50.7%0.07GBP 2.01MGBP 819.00KGBP 18.14M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-14GBX 593.98Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 GBX.

About OptiBiotix Health Plc

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential health benefits.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is OptiBiotix Health Plc's market cap?

OptiBiotix Health Plc's market capitalization is GBX 593.98M.

What does OptiBiotix Health Plc do?

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential health benefits.